Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta

Email Facebook Twitter

Severn Trent CEO Liv Garfield speaking at the Hardman & Co Investor Forum Watch Now

Severn Trent CEO Liv Garfield speaking at the Hardman & Co Investor Forum
TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake

Glaxosmithkline Share Chat (GSK)

Share Price: 1,588.80Bid: 1,589.00Ask: 1,589.20Change: -16.80 (-1.05%)Faller - Glaxosmithkline
Spread: 0.20Spread as %: 0.01%Open: 1,601.40High: 1,604.40Low: 1,587.20Yesterday’s Close: 1,605.60

Share Discussion for Glaxosmithkline

View all GSK Messages

Please login or register to post a message on Share Chat.

Posts per page:

Posts: 792
Opinion:No Opinion
RE: Damned aussies ...
26 May '19
Thx AllAtSea - good to know. Nevertheless, think you are being optimistic about buying 2 houses in Chelsea for £3m. You cannot even get a parking space for that.
Good news this week all round for GSK : Shingles approval in China, sales rep incentives re-introduced, and India Competition Committee approval of healthcare tie-up with Pfiser.
Posts: 923
Opinion:No Opinion
RE: Damned aussies ...
20 May '19
About £3m if ACCC vs Reckitt Benckiser is a guide. That'd buy you nearly two houses in Kensington and Chelsea.
Posts: 792
Opinion:No Opinion
Damned aussies ...
19 May '19
From London South East no less - but I could not find it anywhere on this site. Wonder how much this is going to cost ?

GSK and Novartis have admitted breaching Australian consumer law around Voltaren Osteo Gel and Voltaren Emulgel pain relief products by making "false or misleading representations in the marketing" of the two products.

From January 2012 to March 2017, the companies marketed Osteo Gel as a more effective treatment for pain and inflammation caused by osteoarthritis than Emulgel. In fact, the two medications are "essentially the same".

A later hearing will take place to "determine penalties sought by the ACCC".

Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk

Home  |  Contact Us  |  About Us  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy  |  Mobile Site  |  About this website design

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.